CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-23 | Cambrian BioPharma Inc 10% owner | Purchase | +9,500 | $14.34 | $136K | 4,798,293 |
| 2021-03-23 | Peyer James Director | Purchase | +10,000 | $14.34 | $143K | 4,798,794 |
| 2021-03-23 | Cambrian BioPharma Inc 10% owner | Purchase | +10,000 | $14.34 | $143K | 4,798,794 |
| 2021-03-22 | Cambrian BioPharma Inc 10% owner | Purchase | +2,183 | $15.02 | $33K | 4,788,794 |
| 2021-03-22 | Peyer James Director | Purchase | +2,183 | $15.02 | $33K | 4,788,794 |
| 2021-03-18 | Cambrian BioPharma Inc 10% owner | Purchase | +817 | $15.25 | $12K | 4,786,611 |
| 2021-03-18 | Peyer James Director | Purchase | +817 | $15.25 | $12K | 4,786,611 |
| 2021-03-08 | Peyer James Director | Purchase | +1,000 | $15.25 | $15K | 4,785,794 |
| 2021-03-08 | Cambrian BioPharma Inc 10% owner | Purchase | +1,000 | $15.25 | $15K | 4,785,794 |
| 2021-03-05 | Cambrian BioPharma Inc 10% owner | Purchase | +8,000 | $13.75 | $110K | 4,784,794 |
| 2021-03-05 | Peyer James Director | Purchase | +8,000 | $13.75 | $110K | 4,784,794 |
| 2021-03-04 | Cambrian BioPharma Inc 10% owner | Purchase | +2,000 | $14.13 | $28K | 4,776,794 |
| 2021-03-04 | Peyer James Director | Purchase | +2,000 | $14.13 | $28K | 4,776,794 |
| 2021-03-03 | Cambrian BioPharma Inc 10% owner | Purchase | +3,000 | $15.85 | $48K | 4,774,794 |
| 2021-03-03 | Peyer James Director | Purchase | +3,000 | $15.85 | $48K | 4,774,794 |
| 2021-03-02 | Peyer James Director | Purchase | +3,000 | $16.25 | $49K | 4,771,794 |
| 2021-03-02 | Cambrian BioPharma Inc 10% owner | Purchase | +3,000 | $16.25 | $49K | 4,771,794 |
| 2021-02-26 | Peyer James Director | Purchase | +5,000 | $16.25 | $81K | 4,768,794 |
| 2021-02-26 | Cambrian BioPharma Inc 10% owner | Purchase | +5,000 | $16.25 | $81K | 4,768,794 |
| 2021-02-25 | Peyer James Director | Purchase | +12,000 | $15.79 | $189K | 4,763,794 |
Page 18 of 20 · 385 trades